Cargando…

Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease

Parkinson’s disease (PD) is primarily idiopathic and a highly heterogenous neurodegenerative disease with patients experiencing a wide array of motor and non-motor symptoms. A major challenge for understanding susceptibility to PD is to determine the genetic and environmental factors that influence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jeffrey, Daadi, Etienne W., Oh, Thomas, Daadi, Elyas S., Daadi, Marcel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689743/ https://www.ncbi.nlm.nih.gov/pubmed/36360174 http://dx.doi.org/10.3390/genes13111937

Ejemplares similares

LRRK2 Attenuates Antioxidant Response in Familial Parkinson’s Disease Derived Neural Stem Cells
por: Kim, Jeffrey, et al.
Publicado: (2023)

Age-related cognitive decline in baboons: modeling the prodromal phase of Alzheimer's disease and related dementias
por: Lizarraga, Stephanny, et al.
Publicado: (2020)

Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson’s disease
por: Choudhury, Gourav R., et al.
Publicado: (2018)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
por: Yang, Guang, et al.
Publicado: (2018)

Adherent Self-Renewable Human Embryonic Stem Cell-Derived Neural Stem Cell Line: Functional Engraftment in Experimental Stroke Model
por: Daadi, Marcel M., et al.
Publicado: (2008)

Dopaminergic Neurons from Midbrain-Specified Human Embryonic Stem Cell-Derived Neural Stem Cells Engrafted in a Monkey Model of Parkinson’s Disease
por: Daadi, Marcel M., et al.
Publicado: (2012)

Nonhuman primate model in clinical modeling of diseases for stem cell therapy
por: Choudhury, Gourav R, et al.
Publicado: (2016)

Assessing farmers’ attitudes to, and the behavioural costs of, organic fertiliser practices in northern Ghana: An application of the behavioural cost approach
por: Daadi, Bunbom Edward, et al.
Publicado: (2021)

Coat Color-Facilitated Efficient Generation and Analysis of a Mouse Model of Down Syndrome Triplicated for All Human Chromosome 21 Orthologous Regions
por: Li, Yichen, et al.
Publicado: (2021)

Magnetic Resonance Imaging‐Guided Delivery of Neural Stem Cells into the Basal Ganglia of Nonhuman Primates Reveals a Pulsatile Mode of Cell Dispersion
por: Malloy, Kristen E., et al.
Publicado: (2016)

Challenges involved in cell therapy for Parkinson’s disease using human pluripotent stem cells
por: Moon, Heechang, et al.
Publicado: (2023)

Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
por: Byers, Blake, et al.
Publicado: (2012)

The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
por: Kang, Ji-feng, et al.
Publicado: (2016)

Using induced pluripotent stem cells for modeling Parkinson’s disease
por: Ke, Minjing, et al.
Publicado: (2019)

Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
por: Hu, Xinchao, et al.
Publicado: (2020)

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

Non-human primate pluripotent stem cells for the preclinical testing of regenerative therapies
por: Rodriguez-Polo, Ignacio, et al.
Publicado: (2022)

Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases
por: Yefroyev, David A, et al.
Publicado: (2022)

Cell therapy for Parkinson’s disease with induced pluripotent stem cells
por: Morizane, Asuka
Publicado: (2023)

Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research
por: Wehbe, Zeinab, et al.
Publicado: (2021)

Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
por: Eschenhagen, Thomas, et al.
Publicado: (2018)

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
por: Li, Hong, et al.
Publicado: (2018)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
por: Spathopoulou, Angeliki, et al.
Publicado: (2022)

A Comprehensive Library of Familial Human Amyotrophic Lateral Sclerosis Induced Pluripotent Stem Cells
por: Li, Ying, et al.
Publicado: (2015)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells
por: Mishima, Takayasu, et al.
Publicado: (2018)

Phenotypical, functional and transcriptomic comparison of two modified methods of hepatocyte differentiation from human induced pluripotent stem cells
por: Li, Rong, et al.
Publicado: (2022)

Pluripotency of induced pluripotent stem cells
por: Kang, Lan, et al.
Publicado: (2012)

Pluripotency of Induced Pluripotent Stem Cells
por: Feng, Chunjing, et al.
Publicado: (2013)

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
por: Devine, Michael J., et al.
Publicado: (2011)

Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells
por: Stoddard-Bennett, Theo, et al.
Publicado: (2019)

Genetic Correction of Tauopathy Phenotypes in Neurons Derived from Human Induced Pluripotent Stem Cells
por: Fong, Helen, et al.
Publicado: (2013)

Pluripotent stem cells for Parkinson's disease: progress and challenges
por: Zeng, Xianmin, et al.
Publicado: (2013)

Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
por: Coccia, Elena, et al.
Publicado: (2021)

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research
por: Stover, Alexander E., et al.
Publicado: (2016)

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
por: Kouroupi, Georgia, et al.
Publicado: (2020)

Induced pluripotent stem cell‐based modeling of mutant LRRK2‐associated Parkinson's disease
por: Weykopf, Beatrice, et al.
Publicado: (2019)

Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model
por: Sahakyan, Vardine, et al.
Publicado: (2018)

Advances in Recapitulating Alzheimer’s Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models
por: Hasan, Md Fayad, et al.
Publicado: (2022)

Patient-specific pluripotent stem cell-based Parkinson’s disease models showing endogenous alpha-synuclein aggregation
por: Oh, Yohan
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nujpk39n8tvurst0q5nmqqrlrr